Inozyme Pharma Inc (INZY) Stock
INZY is no longer traded. Inozyme Pharma Inc was delisted from the Nasdaq in June 2025.
Prices on this page are historical; the last trade was June 30, 2025 at $4.00.
Inozyme Pharma Inc stock price history
INZY final trading statistics
- Final close
- $4.00
- Final trading day
- Jun 30, 2025
- Market cap at delisting
- $258.25M
- Shares outstanding
- 64.56M
- Final 52-week range
- $0.72 – $6.24
- Avg. volume (final 3 mo.)
- 2,226,011
- All-time high (split-adj.)
- $30.20 · Sep 2020
- All-time low (split-adj.)
- $0.82 · Apr 2025
- Return since IPO
- -77.2%
- Beta
- 2.29
- Book value / share
- $0.49
- Price / book
- 8.11
Inozyme Pharma Inc annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$102.0M | -$1.63 |
| FY2023 | $0.00 | -$71.2M | -$1.37 |
| FY2022 | $0.00 | -$65.4M | -$1.89 |
| FY2021 | $0.00 | -$56.4M | -$2.39 |
| FY2020 | $0.00 | -$55.8M | -$10.99 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Inozyme Pharma Inc
Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for rare diseases that affect bone health and blood vessel function. The company's lead product candidate consists of INZ-701, a soluble, recombinant, genetically engineered, and ENPP1 fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, and calciphylaxis, as well as patients with end-stage kidney disease receiving hemodialysis. It also develops Next Gen ERT for the treatment of ossification of the posterior longitudinal ligament (OPLL); and Gene therapy, a disease of the PPi-Adenosine Pathway. The company has license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Inozyme Pharma Inc stock FAQ
What happened to Inozyme Pharma Inc stock?
Inozyme Pharma Inc stock was delisted from the Nasdaq. Its final close was $4.00 on June 30, 2025.
Is INZY stock still trading?
No. INZY was delisted from the Nasdaq in June 2025 and no longer trades on a U.S. exchange.
What was the last price of INZY stock?
INZY closed at $4.00 on its final trading day, June 30, 2025, for a market value of about $258.25M.
What were Inozyme Pharma Inc's revenue and earnings in its last full fiscal year?
Inozyme Pharma Inc reported revenue of $0.00 and net income of -$102.0M in fiscal 2024, its last full year as a public company.
When did Inozyme Pharma Inc go public?
Inozyme Pharma Inc stock began trading on July 24, 2020.